Answers are grounded in this paper and cite their sources.
Recently, the use of 4 He particles in cancer radiotherapy has been reconsidered as they potentially represent a good compromise between protons and 12 C ions. The first step to achieve this goal is the development of a dedicated treatment planning system, for which basic physics information such as the characterization of the beam lateral scattering and fragmentation cross sections are required. In the present work, the attenuation of 4 He primary particles and the build-up of secondary charged fragments at various depths in water and polymethyl methacrylate were investigated experimentally for 120 and 200 MeV u −1 beams delivered by the synchrotron at the Heidelberg Ion-Beam Therapy Center, Heidelberg. Species and isotope identification was accomplished combining energy loss and time-of-flight measurements. Differential yields and energy spectra of all fragments types were recorded between 0° and 20° with respect to the primary beam direction.
No takes yet. Share an insight, caveat, or question.
Rovituso et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: